| Просмотров | |
|---|---|
| Pharmacoepidemiologic and clinical rationale for the inclusion of L-arginine and dihydroquercetin in the combined pharmacotherapy of hypertensive patients with COVID-19 | 1 |
| Март 2025 | Апрель 2025 | Май 2025 | Июнь 2025 | Июль 2025 | Август 2025 | Сентябрь 2025 | |
|---|---|---|---|---|---|---|---|
| Pharmacoepidemiologic and clinical rationale for the inclusion of L-arginine and dihydroquercetin in the combined pharmacotherapy of hypertensive patients with COVID-19 | 0 | 0 | 0 | 0 | 0 | 1 | 0 |
| Просмотров |
|---|
| Просмотров | |
|---|---|
| Соединенное Королевство | 1 |
| Просмотров | |
|---|---|
| Warrington | 1 |